Published in Thromb Haemost on September 07, 1992
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J (1995) 1.38
Bezafibrate in men with lower extremity arterial disease: randomised controlled trial. BMJ (2002) 1.19
Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN4119421]. Curr Control Trials Cardiovasc Med (2001) 1.13
Hemorheology and microvascular disorders. Korean Circ J (2011) 0.85
Profiling plasma peptides for the identification of potential ageing biomarkers in Chinese Han adults. PLoS One (2012) 0.84
Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men. J Thromb Haemost (2010) 0.82
Prothrombin time derived fibrinogen determination on Sysmex CA-6000. J Clin Pathol (1998) 0.81
Fibrinogen and cardiovascular disease. J Clin Pathol (1997) 0.80
Sedentary behavior is associated with impaired biomarkers in claudicants. J Vasc Surg (2015) 0.77
New circulating biomarkers for predicting cardiovascular death in healthy population. J Cell Mol Med (2015) 0.75
Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case-Control Study. Front Cardiovasc Med (2017) 0.75
A growth chart for premature and other infants. Arch Dis Child (1971) 8.04
Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab (2001) 7.53
Prevalence of urinary incontinence. Br Med J (1980) 7.11
A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature (2001) 6.78
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet (1986) 6.51
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 5.17
Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell (1989) 5.12
Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ (1994) 5.07
The trouble with ethics committees. J R Coll Physicians Lond (1994) 5.07
Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet (1994) 4.85
Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ (1992) 4.53
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem (2001) 4.51
Accuracy of diagnosis on death certificates compared with that in hospital records. Br J Prev Soc Med (1967) 4.17
Leg ulcers: epidemiology and aetiology. Br J Surg (1986) 3.91
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut (2005) 3.86
Randomised trial of personalised computer based information for cancer patients. BMJ (1999) 3.82
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Strategies for prevention of osteoporosis and hip fracture. BMJ (1991) 3.78
Haemostatic function and cardiovascular death: early results of a prospective study. Lancet (1980) 3.25
Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1999) 3.08
Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet (1993) 3.03
Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res (1992) 2.99
Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico. Virology (1995) 2.99
Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J (1979) 2.98
Population-based distributions of haemostatic variables. Br Med Bull (1977) 2.83
Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost (2000) 2.74
Multicentre trial of physiotherapy in the management of sciatic symptoms. Lancet (1981) 2.59
Fetal and infant growth and cardiovascular risk factors in women. BMJ (1995) 2.52
How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf) (1992) 2.49
Faecal bile-acids and clostridia in patients with cancer of the large bowel. Lancet (1975) 2.40
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol (1993) 2.39
Anthropometric determination of leg fat and muscle plus bone volumes in young male and female adults. J Physiol (1969) 2.28
Histopathology of ischemic optic neuropathy. Am J Ophthalmol (1970) 2.24
Repeatability and validity of a modified activities of daily living (ADL) index in studies of chronic disability. Int Rehabil Med (1979) 2.14
Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet (1972) 2.13
Identifying variables associated with inaccurate self-monitoring of blood glucose: proposed guidelines to improve accuracy. Diabetes Educ (2002) 2.12
Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I). J Thromb Haemost (2006) 2.11
Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet (1987) 2.10
Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08
Tissue donation: benefits, legal issues and the nurse's role. Nurs Stand (2006) 2.05
Venous leg ulcers: a prognostic index to predict time to healing. BMJ (1992) 2.05
Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework. BMJ (1991) 2.02
Antithrombin III and arterial disease. Lancet (1991) 1.98
Can EUS alone differentiate between malignant and benign cystic lesions of the pancreas? Am J Gastroenterol (2001) 1.94
Plasma concentrations of fibrinogen and factor VII in adult life and their relation to intra-uterine growth. Br J Haematol (1995) 1.91
Haemostatic variables associated with diabetes and its complications. Br Med J (1979) 1.90
Acute myoglobinuria associated with heroin addiction. JAMA (1971) 1.88
Long term survival after pancreatic resection for pancreatic adenocarcinoma. Am J Gastroenterol (2001) 1.87
Quantitative studies of dorsal root ganglia and neuropathologic observations on spinal cords in familial dysautonomia. J Neurol Sci (1978) 1.87
Ischaemic heart disease mortality risks for smokers and non-smokers. J Epidemiol Community Health (1979) 1.85
Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet (1987) 1.85
Remedial therapy after stroke: a randomised controlled trial. Br Med J (Clin Res Ed) (1981) 1.84
Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group. JAMA (2000) 1.79
Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ (1999) 1.76
Gastric mucus: isolation and polymeric structure of the undegraded glycoprotein: its breakdown by pepsin. Gastroenterology (1980) 1.74
Use of statins in general practices, 1996-8: cross sectional study. BMJ (2000) 1.73
Changes in haemostatic system after application of a tourniquet. Lancet (1977) 1.70
Interaction of eukaryotic translation initiation factor 4G with the nuclear cap-binding complex provides a link between nuclear and cytoplasmic functions of the m(7) guanosine cap. Mol Cell Biol (2001) 1.68
Fibrinogen: a possible link between social class and coronary heart disease. Br Med J (Clin Res Ed) (1985) 1.67
Relationship of air temperature to various chemical, haematological, and haemostatic variables. J Clin Pathol (1979) 1.65
Reduction in hospital readmission stay of elderly patients by a community based hospital discharge scheme: a randomised controlled trial. BMJ (1988) 1.65
Ethnic group comparisons of variables associated with ischaemic heart disease. Br Heart J (1978) 1.63
Epidemiological and clinical picture of Addison's disease. Lancet (1968) 1.63
EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc (2000) 1.62
Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease. Surgery (1980) 1.61
Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. Br Med J (1980) 1.61
Implications of suspicious findings in breast cancer screening. Arch Surg (1975) 1.60
Dietary and other characteristics relevant for coronary heart disease in men of Indian, West Indian and European descent in London. Atherosclerosis (1988) 1.58
Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen. Lancet (1977) 1.58
Endoscopic management of postoperative biliary complications in orthotopic liver transplantation. Gastrointest Endosc (2000) 1.57
Vibration syndrome in Foresty Commission chain saw operators. Br J Ind Med (1971) 1.56
Virulence of six strains of Mycobacterium bovis (BCG) in mice. Infect Immun (1973) 1.56
Factor VII in an industrial population. Br J Haematol (1974) 1.55
Antithrombotic agents in coronary artery disease. Chest (2001) 1.53
Absence of the tight junctional protein AF-6 disrupts epithelial cell-cell junctions and cell polarity during mouse development. Curr Biol (1999) 1.52
Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection. J Immunother (2001) 1.52
Observer variability in recording the peripheral pulses. Br Heart J (1968) 1.51
Genetic and environmental contributions to size, color, shape, and other characteristics of melanocytic naevi in a sample of adolescent twins. Genet Epidemiol (1999) 1.51
Quantitative studies of sympathetic ganglia and spinal cord intermedio-lateral gray columns in familial dysautonomia. J Neurol Sci (1978) 1.51
Which breast to biopsy: an expanding dilemma. Ann Surg (1976) 1.49
Haemostatic changes that constitute the hypercoagulable state. Lancet (1991) 1.47
Our lives and hard times. Lancet (1975) 1.47
Antithrombin III and procoagulant activity: sex differences and effects of the menopause. Br J Haematol (1990) 1.47
Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol (1994) 1.47